Inactive Instrument

Other languages ITUS Corp Nasdaq

Equities

US45069V2034

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board	Apr. 18
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 12
Anixa Biosciences Initiates Higher Dosing in Phase 1 Study of Ovarian Cancer Treatment	Feb. 12
Anixa Biosciences Says Japan Grants Patent to Ovarian Cancer Vaccine Technology	Jan. 23
Anixa Biosciences, Inc. Announces Japanese Patent on Ovarian Cancer Vaccine Technology	Jan. 23
Anixa Biosciences, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	Jan. 16
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine	Dec. 06
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology	Nov. 27
Anixa Biosciences, Inc. Appoints Mark A. Goldberg, Md, to Its Cancer Business Advisory Board	23-10-23
Anixa Biosciences, Inc. Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial	23-10-13
Anixa Biosciences, Inc. Establishes Cancer Business Advisory Board	23-09-19
Anixa Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-06
Anixa Biosciences Starts Treatment of Third Patient in Clinical Trial of Ovarian Cancer Therapy; Shares Rise	23-08-28
Anixa Biosciences Says Cleveland Clinic Enrolling Patients for Study of Cancer Vaccine Plus Keytruda	23-08-07
Anixa Biosciences, Inc. Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial	23-08-07
Press Release: Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology	23-07-27
Anixa Biosciences Reports Issuance of Canadian Patent for CAR-T Cancer Therapy Technology	23-07-11
Anixa Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-14
Anixa Biosciences, Inc. and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine	23-04-17
Anixa Biosciences Says It Has No Accounts at Collapsed Silicon Valley Bank; Shares Rise	23-03-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ITUS Corp Nasdaq

Equities

US45069V2034

Other languages

Filters